In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors.
Chloé VirolleMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0000-0001-5791-8064 Sibylle FerrarinMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0009-0007-0190-1934 Gaël PanisDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-6926-6224 Yannick BaffertMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.
Annick Dedieu-BerneMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0000-0002-9982-8793 Jérémy GuérinMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.
Julien CayronMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0000-0002-6607-311X Daouda A K TraoréFaculté des Sciences et Techniques, Université des Science Techniques et Technologiques de Bamako (USTTB), Bamako, Mali.ORCID 0000-0003-1001-4716 Sofía Martínez-AbsalónDepartment of Chemical Engineering, University of Rochester, Rochester, New York, USA.ORCID 0000-0003-3183-5468 Rania ZenatiMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.
Sarah BigotMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0000-0002-9340-6303 Yoshiharu YamaichiUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.ORCID 0000-0003-0835-5407 Allison LopatkinDepartment of Chemical Engineering, University of Rochester, Rochester, New York, USA.ORCID 0000-0003-0018-9205 Patrick H ViollierDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-5249-9910 David BursteinThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel.ORCID 0000-0002-6219-1880 Laurent TerradotMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0000-0003-4279-9167 Christian LesterlinMolecular Microbiology and Structural Biochemistry (MMSB), Université Lyon 1, CNRS, Inserm, UMR5086, 69007 Lyon, France.ORCID 0000-0002-9108-0848 Funding
Determinants underlying horizontal gene transfer-mediated pathogen successR35GM150871 · NIGMS · UNIVERSITY OF ROCHESTER · PI Allison Lopatkin · 2023 to 2026
$1.7MNIGMS NIH HHS R35 GM150871
6 · The paper itselfAbstract
Conjugative plasmids are major drivers of antibiotic resistance dissemination, yet how newly transferred plasmids establish in recipient cells remains poorly understood. Here we investigate YfjB, a previously uncharacterized conserved leading-region protein, which is zygotically induced immediately after plasmid entry and acts specifically during the earliest post-transfer stages. Multi-omics analyses reveal that YfjB reprograms host transcription, triggering extensive metabolic rewiring that compensates the transient fitness cost of plasmid acquisition. Structural analyses show that YfjB is a ParB-like protein containing a CTP-binding domain and a helix-turn-helix DNA-binding motif, linked to a previously uncharacterized dimerization module that forms a V-shaped clamp-like architecture compatible with DNA loading. Consistently, live-cell imaging reveals nucleoid-associated foci in transconjugants, and ChIP-seq identifies multiple chromosomal binding sites. We therefore rename the protein HerB (Host Expression Reprogrammer, ParB-like). More broadly, our findings reveal how mobile genetic elements facilitate their dissemination by transiently subverting host physiology.
Indexed as
DNA conjugationHorizontal gene transferlive-cell microscopyplasmid fitness costresistance-plasmid disseminationtranscriptomic reprogrammingzygotic induction
Identifiers
PMID42465341
PMCPMC13370423
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390